Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 30;8(7):e70380.
doi: 10.1371/journal.pone.0070380. Print 2013.

Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies

Cathrine Ebbing  1 , Torvid Kiserud, Synnøve Lian Johnsen, Susanne Albrechtsen, Svein Rasmussen
Affiliations

Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies

Cathrine Ebbing et al. PLoS One. .

Abstract

Objectives: To determine the prevalence of, and risk factors for anomalous insertions of the umbilical cord, and the risk for adverse outcomes of these pregnancies.

Design: Population-based registry study.

Setting: Medical Birth Registry of Norway 1999-2009.

Population: All births (gestational age >16 weeks to <45 weeks) in Norway (623,478 singletons and 11,263 pairs of twins).

Methods: Descriptive statistics and odds ratios (ORs) for risk factors and adverse outcomes based on logistic regressions adjusted for confounders.

Main outcome measures: Velamentous or marginal cord insertion. Abruption of the placenta, placenta praevia, pre-eclampsia, preterm birth, operative delivery, low Apgar score, transferral to neonatal intensive care unit (NICU), malformations, birthweight, and perinatal death.

Results: The prevalence of abnormal cord insertion was 7.8% (1.5% velamentous, 6.3% marginal) in singleton pregnancies and 16.9% (6% velamentous, 10.9% marginal) in twins. The two conditions shared risk factors; twin gestation and pregnancies conceived with the aid of assisted reproductive technology were the most important, while bleeding in pregnancy, advanced maternal age, maternal chronic disease, female foetus and previous pregnancy with anomalous cord insertion were other risk factors. Velamentous and marginal insertion was associated with an increased risk of adverse outcomes such as placenta praevia (OR = 3.7, (95% CI = 3.1-4.6)), and placental abruption (OR = 2.6, (95% CI = 2.1-3.2)). The risk of pre-eclampsia, preterm birth and delivery by acute caesarean was doubled, as was the risk of low Apgar score, transferral to NICU, low birthweight and malformations. For velamentous insertion the risk of perinatal death at term was tripled, OR = 3.3 (95% CI = 2.5-4.3).

Conclusion: The prevalence of velamentous and marginal insertions of the umbilical cord was 7.8% in singletons and 16.9% in twin gestations, with marginal insertion being more common than velamentous. The conditions were associated with common risk factors and an increased risk of adverse perinatal outcomes; these risks were greater for velamentous than for marginal insertion.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Benirschke K, Kaufman P (1990) Pathology of the human placenta. In: Benirschke K, Kaufmann P (editors). Pathology of the Human Placenta, 2nd edition. New York: Springer-Verlag. p. 319.
    1. Eddleman KA, Lockwood CJ, Berkowitz GS, Lapinski RH, Berkowitz RL (1992) Clinical significance and sonographic diagnosis of velamentous umbilical-cord insertion. Am J Perinatol 9: 123–126. - PubMed
    1. Raisanen S, Georgiadis L, Harju M, Keski-Nisula L, Heinonen S (2012) Risk factors and adverse pregnancy outcomes among births affected by velamentous umbilical cord insertion: a retrospective population-based register study. Eur J Obstet Gynecol Reprod Biol (in press). - PubMed
    1. Oyelese Y, Catanzarite V, Prefumo F, Lashley S, Schachter M, et al. (2004) Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 103: 937–942. - PubMed
    1. Cipriano LE, Barth WH, Zaric GS (2010) The cost-effectiveness of targeted or universal screening for vasa praevia at 18–20 weeks of gestation in Ontario. BJOG 117: 1108–1118. - PubMed

Publication types